2022-03-14 |
101 |
Notice of Service |
Fisher, Ph.D. Regarding Invalidity of U.S. Patent Nos. 7,157,584 & 7,572,920 filed by Lupin Limited, Lupin…Buckton, Ph.D., D.SC. Regarding Invalidity of U.S. Patent No. 9,066,936; and (3) [HIGHLY CONFIDENTIAL-OUTSIDE…2020
18 April 2022
1:20-cv-00922
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-07-08 |
4 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,157,584 ;7,572,920 ;9,066,936…2020
18 April 2022
1:20-cv-00922
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2021-07-20 |
67 |
Order - -Memorandum and Order |
three patents but only one term in
one of those patents, U.S. Patent No. 9,066,936 (“the…the
disputed claim term of U.S. Patent No. 9,066,936 (“the ’936 Patent”) is construed as follows:
…reading the entire patent.” Id. at 1321 (internal quotation marks
omitted).
The patent specification…have reviewed the ’936 Patent and the excerpts of the ’936
Patent prosecution history submitted…ultimate question of the proper construction of the patent [is] a question of law,”
although subsidiary fact-finding |
External link to document |
2022-01-09 |
93 |
Notice of Service |
Ph.D., D.Sc. Regarding the Validity of U.S. Patent No. 9,066,936; (2) [HIGHLY CONFIDENTIAL] Expert Report…2020
18 April 2022
1:20-cv-00922
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2022-02-13 |
97 |
Notice of Service |
Ph.D., D.Sc. Regarding Infringement of U.S. Patent No. 9,066,936 filed by Lupin Limited, Lupin Pharmaceuticals…2020
18 April 2022
1:20-cv-00922
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |